1. Alopecia universalis improvement following risankizumab in a psoriasis patient. (25th February 2022) Authors: Martora, F.; Villani, A.; Ocampo‐Garza, S.S.; Fabbrocini, G.; Megna, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 7(2022) Page Start: e543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Herpes zoster after ChAdOx1 nCoV‐19 vaccine: a case series. (14th August 2021) Authors: Vastarella, M.; Picone, V.; Martora, F.; Fabbrocini, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 12(2021) Page Start: e845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rapid improvement in pruritus in atopic dermatitis patients treated with upadacitinib: a real‐life experience. (18th April 2022) Authors: Napolitano, M.; Fabbrocini, G.; Genco, L.; Martora, F.; Potestio, L.; Patruno, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: 1497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al. (31st May 2022) Authors: Martora, F.; Fabbrocini, G.; Nappa, P.; Marasca, C.; Patruno, C.; Scalvenzi, M.; Napolitano, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: e729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reply to 'Cutaneous adverse effects of the available COVID‐19 vaccines in India: A questionnaire‐based study' by Bawane J et al. (30th June 2022) Authors: Potestio, L.; Genco, L.; Villani, A.; Marasca, C.; Fabbrocini, G.; Fornaro, L.; Ruggiero, A.; Martora, F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: e863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reply to 'Development of severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BNT162b2' by Solimani et al. (17th June 2022) Authors: Martora, F.; Fabbrocini, G.; Nappa, P.; Megna, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 10(2022) Page Start: e750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗